Patent 10428325 was granted and assigned to Adaptive Biotechnologies on October, 2019 by the United States Patent and Trademark Office.
Compositions and methods are disclosed for identifying B-cell receptor sequences that bind to corresponding antigens. The disclosed methods and related embodiments permit the identification paired relationships between rearranged gene segments of B-cell receptors with unique antigens.